Serum Growth Arrest Specific Protein 6 (Gas-6) Levels in Patients with Schizophrenia

Özet

Objective: We have investigated serum growth arrest-specific protein 6 (GAS-6) levels from patients with schizophrenia divided into acute phase remission phases as well as control group.Methods: This study was conducted in Psychiatry Department of Istanbul University Cerrahpasa Medical Faculty. The patients who were diagnosed with schizophrenia after regular psychiatric examination according to DSM-IV criteria (n=22) as well as control subjects were included in the study. Schizophrenia patients with acute phase and remission phase were evaluated by Positive and Negative Syndrome Scale (PANSS) and Clinical global Impression Scale (CGI-S). The serum GAS-6 levels of schizophrenia patients during acute phase and remission phase were compared with the serum GAS-6 levels of healthy controls. Serum GAS-6 levels were measured by commercial ELISA kits.Results: No difference was found in serum GAS-6 levels among the three groups; schizophrenia with acute phase, schizophrenia with remission phase, and controls. There were no correlations between serum GAS-6 levels and PANSS and CGI scores.Conclusion: To reach a definitive data and better interpretation about the relationship between GAS-6 and schizophrenia, future studies with larger groups of patients with schizophrenia subdivided by drug naïve and treated with antipsychotics/other treatment modalities and controls are needed.Key words: GAS-6, schizophrenia, acute phase, remission

Abstract

Objective: While there are suggestions for oral hydration times after general anesthesia, there is no published study with regard to sedation. The aim of this prospective study was to determine a safe time for oral intake after pediatric sedation and its association with nausea and vomiting after discharge.Methods: A total of 180 children (aged 1 month to 13 years) sedated for magnetic resonance imaging were randomly assigned into three groups. All patients fasted for 6 hours and were allowed to take clear fluids until 2 hours before sedation with thiopental (3 mg/kg). After the patients were transported to the recovery room, we allowed the patients to drink as much clear fluids as they wanted prior to discharge in group I, 1 hour after the patients met the discharge criteria for group II, and 2 hours after the patients met the discharge criteria for group III. All patients were assessed for vomiting in the recovery room until 1 hour after their first oral hydration. The parents were then telephoned the next day and questioned regarding nausea/vomiting and any unanticipated hospital admission.Results: There were no statistically significant intergroup differences with respect to age, sex, weight, or the ASA status. There was no nausea and vomiting in either the recovery or post discharge period in any group. In the telephone questionnaire, no hospital admissions were reported.Conclusion: Oral hydration just before discharge is safe, and fasting children after discharge for a period of time is unnecessary for patients sedated with thiopental.Key words: Sedation, oral intake, postoperative nausea and vomiting